New onset psoriasis in a patient with chronic inflammatory demyelinating polyneuropathy treated with Rituximab

G Ital Dermatol Venereol. 2020 Dec;155(6):802-803. doi: 10.23736/S0392-0488.18.06180-1. Epub 2018 Oct 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Plasma Exchange
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy*
  • Prednisone / therapeutic use
  • Psoriasis / chemically induced*
  • Psoriasis / immunology
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Rituximab
  • Prednisone